Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-054865
Filing Date
2013-10-22
Accepted
2013-10-22 20:42:55
Documents
1
Period of Report
2013-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd393333.html 4  
1 FORM 4 rrd393333.xml 4 4546
  Complete submission text file 0001181431-13-054865.txt   5862
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Issuer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
Frohlich Mark W (Reporting) CIK: 0001420482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35546 | Film No.: 131164550